BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 15825314)

  • 1. Effect of leucomycins and analogues on binding [14C ]erythromycin to Escherichia coli ribosomes.
    Pestka S; Nakagawa A; Omura S
    Antimicrob Agents Chemother; 1974 Nov; 6(5):606-12. PubMed ID: 15825314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Properties of ribosomes from Streptomyces erythreus and Streptomyces griseus.
    Teraoka H; Tanaka K
    J Bacteriol; 1974 Oct; 120(1):316-21. PubMed ID: 4138441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-activity relationships among the O-acyl derivatives of leucomycin. Correlation of minimal inhibitory concentrations with binding to Escherichia coli ribosomes.
    Omura S; Nakagawa A; Sakakibara H; Okekawa O; Brandsch R
    J Med Chem; 1977 May; 20(5):732-6. PubMed ID: 404425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antagonistic interactions of macrolides and synergimycins on bacterial ribosomes.
    Di Giambattista M; Vannuffel P; Sunazuka T; Jacob T; Omura S; Cocito C
    J Antimicrob Chemother; 1986 Sep; 18(3):307-15. PubMed ID: 3095298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibiotics as probes of ribosome structure: binding of chloramphenicol and erythromycin to polyribosomes; effect of other antibiotics.
    Pestka S
    Antimicrob Agents Chemother; 1974 Mar; 5(3):255-67. PubMed ID: 4599122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of erythromycin analogues on binding of [14C]erythromycin to Escherichia coli ribosomes.
    Pestka S; Lemahieu RA
    Antimicrob Agents Chemother; 1974 Oct; 6(4):479-88. PubMed ID: 4157349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of [14C]chloramphenicol binding to Escherichia coli ribosomes by erythromycin derivatives.
    Pestka S; LeMahieu RA
    Antimicrob Agents Chemother; 1974 Jul; 6(1):39-45. PubMed ID: 15828169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel dimeric derivatives of leucomycins and tylosin, sixteen-membered macrolides.
    Omura S; Miyano K; Matsubara H; Nakagawa A
    J Med Chem; 1982 Mar; 25(3):271-5. PubMed ID: 7040661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross resistance of Escherichia coli B ribosomes to inhibition of the puromycin reaction by erythromycin, spiramycin and chloramphenicol.
    Cerná J; Rychlík I
    Biochim Biophys Acta; 1968 Apr; 157(2):436-8. PubMed ID: 4870247
    [No Abstract]   [Full Text] [Related]  

  • 10. Electronic and lipophilic interactions of macrolides (leucomycin derivatives) with ribosomal receptor sites.
    Mager PP
    Acta Histochem; 1980; 66(1):40-3. PubMed ID: 6776777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding of [3H]tetrahydroleucomycin A3 to Escherichia coli ribosomes and the effect of 3"-O-acyl derivatives of leucomycins on the binding.
    Omura S; Tanaka H; Inokoshi J; Sakakibara H; Fujiwara T
    J Antibiot (Tokyo); 1982 Apr; 35(4):491-6. PubMed ID: 7047480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetics of binding of macrolides, lincosamides, and synergimycins to ribosomes.
    Di Giambattista M; Engelborghs Y; Nyssen E; Cocito C
    J Biol Chem; 1987 Jun; 262(18):8591-7. PubMed ID: 3110150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reaction of some macrolide antibiotics with the ribosome. Labeling of the binding site components.
    Tejedor F; Ballesta JP
    Biochemistry; 1986 Nov; 25(23):7725-31. PubMed ID: 3542032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ribosome-binding activities and antimicrobial activities of tylosin and its related compounds.
    Omura S; Inokoshi J; Matsubara H; Tanaka H
    J Antibiot (Tokyo); 1983 Dec; 36(12):1709-12. PubMed ID: 6662812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of the ribosomal peptidyl transferase reaction by the mycarose moiety of the antibiotics carbomycin, spiramycin and tylosin.
    Poulsen SM; Kofoed C; Vester B
    J Mol Biol; 2000 Dec; 304(3):471-81. PubMed ID: 11090288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The sensitivity of rat liver and yeast mitochondrial ribosomes to inhibitors of protein synthesis.
    Ibrahim NG; Burke JP; Beattie DS
    J Biol Chem; 1974 Nov; 249(21):6806-11. PubMed ID: 4609092
    [No Abstract]   [Full Text] [Related]  

  • 17. Cross resistance of Escherichia coli B. ribosomes to inhibition of the puromycin reaction by erythromycin, spiramycin and chloramphenicol.
    Rychlík I; Cerná J
    Hoppe Seylers Z Physiol Chem; 1968 Aug; 349(8):958-9. PubMed ID: 4878426
    [No Abstract]   [Full Text] [Related]  

  • 18. Correlation of effects of erythromycin analogues on intact bacteria and on [14C]erythromycin binding to Escherichia coli ribosomes.
    Pestka S; Lemahieu R; Miller P
    Antimicrob Agents Chemother; 1974 Oct; 6(4):489-91. PubMed ID: 4157350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrolide resistance in Staphylococcus aureus. Relation between spiramycin-binding to ribosome and inhibition of polypeptide synthesis in a heat inducible-resistant mutant.
    Shimizu M; Saito T; Mitsuhashi S
    Jpn J Microbiol; 1970 Mar; 14(2):155-62. PubMed ID: 5309853
    [No Abstract]   [Full Text] [Related]  

  • 20. Binding of [14C]erythromycin to Escherichia coli ribosomes.
    Pestka S
    Antimicrob Agents Chemother; 1974 Oct; 6(4):474-8. PubMed ID: 4157348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.